Favorable outcome from Zubsolv® patent infringement litigation against Actavis
Nov 16, 2016
OTC Disclosure News Service
Stockholm, Uppsala, Sweden
This release includes additional documents. Select the link(s) below to view.
Orexo Press Release Zubsolv patent infringement litigation outcome announced 16.10.2016.pdf
Copyright © 2016 OTC Markets. All Rights Reserved
The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.